Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Tecentriq / Tecentriq Hybreza (Atezolizumab) Medicine in India

Tecentriq / Tecentriq Hybreza (Atezolizumab)

Medicine name : Tecentriq / Tecentriq Hybreza

Generic name : Atezolizumab

Manufactured By : Genentech, Inc. (Roche)

Indications : Adjuvant treatment of Stage III mismatch repair deficient (dMMR) colon cancer in eligible patients.

Medicine Description : An immunotherapy for eligible patients with Stage III mismatch repair deficient (dMMR) colon cancer. Tecentriq (Atezolizumab) works by blocking the PD-L1 protein, helping the immune system recognise and attack cancer cells.

Product Introduction

Tecentriq / Tecentriq Hybreza (Atezolizumab) is an immunotherapy treatment used in combination with fluoropyrimidine and oxaliplatin chemotherapy for the adjuvant treatment of Stage III mismatch repair-deficient (dMMR) colon cancer. It is prescribed after surgical removal of the primary tumour to help reduce the risk of cancer recurrence. Atezolizumab belongs to a class of medicines called PD-L1 inhibitors, which help the immune system recognise and attack cancer cells.

Tecentriq is administered as an intravenous infusion, while Tecentriq Hybreza is given as a subcutaneous injection into the thigh by a healthcare professional. Both formulations are used alongside the prescribed chemotherapy regimen. Treatment schedules and duration are determined by the oncologist based on the patient's age, condition and response to therapy.

Common side effects may include fatigue, nausea, diarrhoea, constipation, decreased appetite, rash, peripheral neuropathy and changes in blood cell counts. Serious complications may include immune-mediated inflammation of the lungs, liver, intestines, kidneys and other organs, as well as severe infusion or injection reactions. Regular medical monitoring is important, and patients should promptly report breathing difficulties, persistent diarrhoea, yellowing of the skin or severe abdominal pain.

Uses Of Tecentriq / Tecentriq Hybreza (Atezolizumab)

Adjuvant Treatment of Stage III dMMR Colon Cancer

Benefits Of Tecentriq / Tecentriq Hybreza

Used in combination with fluoropyrimidine and oxaliplatin chemotherapy after surgery to treat Stage III mismatch repair-deficient (dMMR) colon cancer and help reduce the risk of cancer recurrence.

Side Effects Of Tecentriq / Tecentriq Hybreza (Atezolizumab)

Some side effects may occur when Tecentriq / Tecentriq Hybreza (Atezolizumab) is used with fluoropyrimidine and oxaliplatin chemotherapy. Inform your doctor if any side effect persists or becomes severe.

Common Side Effects of Tecentriq / Tecentriq Hybreza (Atezolizumab)

  • Nausea
  • Diarrhoea
  • Peripheral neuropathy (numbness or tingling in hands and feet)
  • Decreased appetite
  • Abdominal pain
  • Constipation
  • Cough
  • Shortness of breath
  • Mouth swelling or sores
  • Vomiting
How To Use Tecentriq / Tecentriq Hybreza

Tecentriq is administered through an intravenous infusion by a healthcare professional, while Tecentriq Hybreza is injected under the skin of the thigh. Both are given in combination with fluoropyrimidine and oxaliplatin chemotherapy according to the oncologist's prescribed schedule. For this colon cancer indication, treatment generally includes 6 months of combination therapy followed by 6 months of atezolizumab alone, or until disease recurrence or unacceptable toxicity.

How Tecentriq / Tecentriq Hybreza (Atezolizumab) Works

Atezolizumab is a PD-L1 checkpoint inhibitor that blocks the PD-L1 protein from binding to PD-1 and B7.1 receptors. This helps restore immune-cell activity, allowing the body's immune system to recognise and attack cancer cells. When combined with chemotherapy, it helps target cancer cells through complementary mechanisms.

Storage Conditions
  • Store unopened vials in a refrigerator between 2°C and 8°C.
  • Keep the vials in their original carton to protect them from light.
  • Do not freeze or shake the medicine.
  • Keep the medicine in a secure place and allow healthcare professionals to handle its preparation and storage.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Avoid excessive alcohol consumption during treatment. Consult your doctor, as alcohol may worsen nausea, fatigue or other treatment-related side effects.

PregnancyPregnancy CONSULT YOUR DOCTOR

Atezolizumab may harm an unborn baby. Avoid pregnancy during treatment and use effective contraception during treatment and for at least 5 months after the last dose.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment and for at least 5 months after the last dose. Consult your doctor before breastfeeding again.

DrivingDriving CONSULT YOUR DOCTOR

Treatment may cause fatigue, dizziness or weakness. Avoid driving or operating machinery if these symptoms affect your alertness.

KidneyKidney CAUTION

Inform your doctor if you have kidney disease. Kidney inflammation and changes in kidney function may occur, so regular monitoring may be necessary.

LiverLiver CAUTION

Inform your doctor about any existing liver condition. Atezolizumab may cause immune-mediated liver inflammation, requiring regular liver function tests.

Quick Tips
  • Receive treatment only under the supervision of a qualified oncologist.
  • Follow the prescribed chemotherapy and immunotherapy schedule without missing appointments.
  • Attend regular blood tests and medical check-ups to monitor treatment effects.
  • Report persistent diarrhoea, breathing difficulties, unusual fatigue or yellowing of the skin promptly.
  • Use effective contraception during treatment and for at least 5 months after the last dose.
  • Read More About - Tecentriq / Tecentriq Hybreza (Atezolizumab) from Pharma Five.
About Pharma Five

Pharma Five supports patients seeking Tecentriq / Tecentriq Hybreza (Atezolizumab) by facilitating the import of limited quantities for personal medical treatment, subject to applicable regulations. Depending on the requirements, Form 12A, a valid prescription from a Registered Medical Practitioner (RMP), and other supporting documents may be necessary.

With over 20 years of pharmaceutical industry experience, Pharma Five offers specialised consultancy and medicine import assistance for patients requiring Tecentriq / Tecentriq Hybreza (Atezolizumab). The team helps patients understand the documentation requirements and navigate the relevant import procedures for accessing this treatment. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB11595
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761347s011lbl.pdf
  3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761347s011lbl.pdf
  4. https://dailymed-beta.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fa682c9-a312-4932-9831-f286908660ee
Faq

General Question

Tecentriq (Atezolizumab) and Tecentriq Hybreza (Atezolizumab + Hyaluronidase-tqjs) are immunotherapy treatments used with fluoropyrimidine and oxaliplatin chemotherapy for Stage III dMMR colon cancer after surgery.

Atezolizumab blocks the PD-L1 protein, helping the immune system recognise and attack cancer cells.

Tecentriq is approved for adults and children aged 2 years and older with Stage III dMMR colon cancer. Tecentriq Hybreza is approved for adults and eligible children aged 12 years and older weighing at least 40 kg.

Tecentriq is administered through an intravenous infusion, while Tecentriq Hybreza is injected under the skin of the thigh by a healthcare professional. Both are given with prescribed chemotherapy.

Common side effects may include nausea, diarrhoea, fatigue, constipation, decreased appetite, abdominal pain, rash, vomiting, cough and peripheral neuropathy.

Yes. Serious side effects may include immune-mediated inflammation of the lungs, liver, intestines, kidneys and hormone-producing glands, as well as severe infusion reactions.

Treatment generally involves six months of atezolizumab with chemotherapy, followed by six months of atezolizumab alone, or until disease recurrence or unacceptable toxicity.

Consult your doctor before consuming alcohol during treatment. Avoid excessive alcohol consumption, particularly if you experience treatment-related side effects.

Atezolizumab may harm an unborn baby. Avoid pregnancy during treatment and use effective contraception during treatment and for at least 5 months after the last dose.

Atezolizumab may interact with other treatments or affect immune-related conditions. Inform your doctor about all medicines, supplements and previous treatments.

If you miss a scheduled infusion or injection, contact your healthcare provider as soon as possible to arrange the next dose. Do not attempt to make up a dose yourself.

Tecentriq and Tecentriq Hybreza are administered by healthcare professionals, so food intake does not affect their administration.

Inform your doctor about autoimmune diseases, organ transplants or previous immune-related conditions. Attend regular blood tests and report persistent diarrhoea, breathing difficulties or unusual fatigue.

Store unopened Tecentriq and Tecentriq Hybreza vials in a refrigerator between 2°C and 8°C. Keep them in their original cartons, protect from light and do not freeze.

Pharma Five may assist patients seeking Tecentriq or Tecentriq Hybreza through pharmaceutical consultancy and medicine import support, subject to applicable regulations and required medical documentation. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources